Ameritas Investment Partners, Inc. Fibrogen Inc Transaction History

Ameritas Investment Partners, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$37.09 - $48.97 $10,459 - $13,809	-282 Reduced 3.84%	7,057 $262,000
Q2 2020 Aug 05, 2020	BUY	$32.57 - $42.83 $11,757 - $15,461	361 Added 5.17%	7,339 $297,000
Q1 2020 May 13, 2020	BUY	$23.3 - $45.96 $4,683 - $9,237	201 Added 2.97%	6,978 $242,000
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $6,155 - $8,554	178 Added 2.7%	6,777 $291,000
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $12,892 - $20,379	367 Added 5.89%	6,599 $298,000
Q2 2018 Aug 13, 2018	BUY	$44.9 - $64.95 $12,347 - $17,861	275 Added 4.62%	6,232 $390,000
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $10,026 - $14,363	239 Added 4.18%	5,957 $282,000
Q3 2017 Nov 15, 2017	BUY	$33.4 - $53.9 $16,700 - $26,950	500 Added 9.58%	5,718 $275,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,218	5,218 $169,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.